AB52459

FITC Anti-Cytokeratin 18 抗体 [C-04]

Name: FITC Anti-Cytokeratin 18 抗体 [C-04] (ab52459) | Abcam
Brand: Abcam Limited
SKU: AB52459
Price: 73000 JPY
Availability: InStock

FITC Anti-Cytokeratin 18 antibody [C-04]

Be the first to review this product! Submit a review

(16 Publications)

Anti-Cytokeratin 18 antibody [C-04] conjugated to FITC - suitable for intracellular flow cytometry, ICC, and reacts with human samples. Clone [C-04] is a mouse monoclonal antibody cited in 10 publications.

別名を表示する

CYK18, PIG46, KRT18, Cell proliferation-inducing gene 46 protein, Cytokeratin-18, Keratin-18, CK-18, K18

5 Images

Flow Cytometry (Intracellular) - FITC Anti-Cytokeratin 18 antibody [C-04] (AB52459)

Flow Cyt (Intra)

Lab

Flow Cytometry (Intracellular) - FITC Anti-Cytokeratin 18 antibody [C-04] (AB52459)

Overlay histogram showing intracellular staining of HeLa cells labeled with ab52459 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab52459, 1μg/1x10⁶ cells) for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 (FITC) (2μg/1x10⁶ cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HeLa cells fixed with 4% paraformaldehyde (10 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.

Unknown

Immunocytochemistry - FITC Anti-Cytokeratin 18 antibody [C-04] (AB52459)

ICC/IF image of ab52459 stained HCT116 cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab52459, 5µg/ml) overnight at +4°C. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - FITC Anti-Cytokeratin 18 antibody [C-04] (AB52459)

Flow cytometry (Intracellular) analysis HeLa (human cervix carcinoma cell line) cells labeling Cytokeratin 18 with ab52459 (red). Overlay with Isotype mouse IgG1 control FITC antibody (blue).

Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - FITC Anti-Cytokeratin 18 antibody [C-04] (AB52459)

Flow cytometric intracellular analysis of human peripheral whole blood spiked with HeLa cells labelling Cytokeratin 18 with ab52459 at 1.67 μg/ml.

Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - FITC Anti-Cytokeratin 18 antibody [C-04] (AB52459)

Flow cytometric intracellular analysis of HeLa cells (red-filled) from neutrophil granulocytes (black-dashed) labelling Cytokeratin 18 with ab52459 at 1.67 μg/ml.

Key facts

宿主種

Mouse

クローン性

Monoclonal

クローン番号

C-04

アイソタイプ

IgG1

標識

FITC

励起波長/蛍光波長

Ex: 495nm, Em: 519nm

キャリアフリー

交差種

Human

アプリケーション

ICC, Flow Cyt (Intra)

applications

免疫原

Cell preparation containing KRT18 protein. The exact immunogen used to generate this antibody is proprietary information.

P05783

style

left-column

style

left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICC" : {"fullname" : "Immunocytochemistry", "shortname":"ICC"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ICC-species-checked": "testedAndGuaranteed", "ICC-species-dilution-info": "5 µg/mL", "ICC-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1-2 µg/mL", "FlowCytIntra-species-notes": "<p><a href='/products/primary-antibodies/fitc-mouse-igg1-b11-6-isotype-control-ab91356'>ab91356</a> - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.</p>" }, "Mammals": { "ICC-species-checked": "predicted", "ICC-species-dilution-info": "", "ICC-species-notes": "", "FlowCytIntra-species-checked": "predicted", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" } } }

style

left-column

style

left-column

出荷温度及び保存条件

製品の状態

Liquid

精製方法

Affinity purification Protein A

精製に関する特記事項

Prior to conjugation, the antibody was purified by Protein A affinity chromatography. The purified antibody is conjugated with Fluorescein isothiocyanate (FITC) under optimum conditions. The reagent is free of unconjugated FITC. Purity >95% by SDS-PAGE.

バッファー組成

pH: 7.4 Preservative: 0.097% Sodium azide Constituents: PBS, 0.2% BSA

出荷温度

Blue Ice

短期保存温度

+4°C

長期保存温度

+4°C

style

left-column

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

Cytokeratin 18 (CK18) also known as Keratin 18 or KRT18 is a type I intermediate filament protein with a molecular weight of approximately 45 kDa. It plays a mechanical role in stabilizing epithelial cell structure and function. CK18 is expressed in single-layered epithelial tissues such as the liver intestine and pancreas. It partners with the type II keratin usually KRT8 to form a stable cytoskeletal network in these cells providing structural integrity and resilience.

Biological function summary

CK18 maintains cellular integrity and mediates resistance to mechanical and non-mechanical stresses in epithelial cells. It forms heterodimers with KRT8 participating in a complex network of filaments important for maintaining cell shape and stability. This organization plays a role in managing cell survival during stress and apoptosis helping regulate cellular functions and responses in tissues where it is expressed.

Pathways

Cytokeratin 18 is involved in the apoptosis and cellular stress response pathways. It interacts with proteins such as caspases during apoptosis facilitating cytoskeletal reorganization and cell fragmentation. CK18 in coordination with KRT8 also participates in signaling pathways that regulate cell cycle and apoptotic processes underlining its importance in cellular turnover and tissue homeostasis.

Elevated levels of CK18 fragments are often observed in cases of non-alcoholic steatohepatitis (NASH) and breast cancer. It serves as a biomarker for liver injury due to its abundance in hepatocytes and release upon cell death. In breast cancer alterations in CK18 expression can reflect disease progression where it interacts with other proteins such as vimentin indicating epithelial-to-mesenchymal transition a process that facilitates metastasis.

style

left-column

style

left-column

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

Visit the General protocols
Visit the Troubleshooting

style

left-column

ターゲットの情報

Required for the formation of KRT8/KRT18 filaments that are involved in ARHGEF40-mediated actin stress fiber formation and tensional force-induced stress fiber formation and reinforcement (PubMed : 26823019). Also acts downstream of ROCK kinase activation as part of a positive feedback mechanism in response to cellular mechanical stress loading (PubMed : 26823019). Organization and orientation of KRT18 filaments are responsible for the properly elongated morphology of epithelial tubules (By similarity). Involved in the uptake of thrombin-antithrombin complexes by hepatic cells (By similarity). When phosphorylated, plays a role in filament reorganization. Involved in the delivery of mutated CFTR to the plasma membrane. Together with KRT8, is involved in interleukin-6 (IL-6)-mediated barrier protection.

See full target information KRT18

style

left-column

文献 (16)

Recent publications for all applications. Explore the full list and refine your search

Cancer immunology research 13:729-748 PubMed40249209

2025

Antitumor CD4+ T Helper 1 Cells Target and Control the Outgrowth of Disseminated Cancer Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Ganesan Ramamoorthi,Marie Catherine Lee,Carly M Farrell,Colin Snyder,Saurabh K Garg,Amy L Aldrich,Vincent Lok,William Dominguez-Viqueira,Sy K Olson-Mcpeek,Marilin Rosa,Namrata Gautam,Shari Pilon-Thomas,Ling Cen,Krithika N Kodumudi,Doris Wiener,Thordur Oskarsson,Ana P Gomes,Robert A Gatenby,Brian J Czerniecki

International journal of molecular sciences 25: PubMed39519007

2024

Development and Characterization of a Human Mammary Epithelial Cell Culture Model for the Blood-Milk Barrier-A Contribution from the ConcePTION Project.

Applications

Unspecified application

Species

Unspecified reactive species

Debora La Mantia,Nina Nauwelaerts,Chiara Bernardini,Augusta Zannoni,Roberta Salaroli,Qi Lin,Isabelle Huys,Pieter Annaert,Monica Forni

Pharmaceutics 14: PubMed36559089

2022

Encorafenib Acts as a Dual-Activity Chemosensitizer through Its Inhibitory Effect on ABCC1 Transporter In Vitro and Ex Vivo.

Applications

Unspecified application

Species

Unspecified reactive species

Yu Zhang,Dimitrios Vagiannis,Youssif Budagaga,Ziba Sabet,Ivo Hanke,Tomáš Rozkoš,Jakub Hofman

International journal of molecular sciences 23: PubMed36430819

2022

Talazoparib Does Not Interact with ABCB1 Transporter or Cytochrome P450s, but Modulates Multidrug Resistance Mediated by ABCC1 and ABCG2: An in Vitro and Ex Vivo Study.

Applications

Unspecified application

Species

Unspecified reactive species

Ziba Sabet,Dimitrios Vagiannis,Youssif Budagaga,Yu Zhang,Eva Novotná,Ivo Hanke,Tomáš Rozkoš,Jakub Hofman

Translational cancer research 11:2636-2646 PubMed36093536

2022

Detection of circulating tumor cells and evaluation of epithelial-mesenchymal transition patterns of circulating tumor cells in ovarian cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Xiao-Xiang Jie,Meng Zhang,Ming Du,Qing-Qing Cai,Qing Cong,Cong-Jian Xu,Xiao-Yan Zhang

Cancer gene therapy 29:1463-1476 PubMed35393570

2022

TMPRSS2-ERG promotes the initiation of prostate cancer by suppressing oncogene-induced senescence.

Applications

Unspecified application

Species

Unspecified reactive species

Lei Fang,Dongmei Li,JuanJuan Yin,Hong Pan,Huihui Ye,Joel Bowman,Brian Capaldo,Kathleen Kelly

International journal of molecular sciences 22: PubMed34769363

2021

Tepotinib Inhibits Several Drug Efflux Transporters and Biotransformation Enzymes: The Role in Drug-Drug Interactions and Targeting Cytostatic Resistance In Vitro and Ex Vivo.

Applications

Unspecified application

Species

Unspecified reactive species

Dimitrios Vagiannis,Youssif Budagaga,Anselm Morell,Yu Zhang,Eva Novotná,Adam Skarka,Sarah Kammerer,Jan-Heiner Küpper,Ivo Hanke,Tomáš Rozkoš,Jakub Hofman

Animals : an open access journal from MDPI 11: PubMed34359140

2021

Development of a Pig Mammary Epithelial Cell Culture Model as a Non-Clinical Tool for Studying Epithelial Barrier-A Contribution from the IMI-ConcePTION Project.

Applications

Unspecified application

Species

Unspecified reactive species

Chiara Bernardini,Debora La Mantia,Roberta Salaroli,Augusta Zannoni,Nina Nauwelaerts,Neel Deferm,Domenico Ventrella,Maria Laura Bacci,Giuseppe Sarli,Michele Bouisset-Leonard,Pieter Annaert,Monica Forni

Animals : an open access journal from MDPI 9: PubMed31640289

2019

Induction of Chemerin on Autophagy and Apoptosis in Dairy Cow Mammary Epithelial Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Bianhong Hu,Wenjuan Song,Yujie Tang,Mingyan Shi,Huixia Li,Debing Yu

International journal of molecular sciences 20: PubMed31618976

2019

The Potential of the FSP1cre- Mouse Model for Studying Juvenile NAFLD.

Applications

Unspecified application

Species

Unspecified reactive species

Jiapeng Chen,Yan Zhuang,Ming Keat Sng,Nguan Soon Tan,Walter Wahli

View all publications

style

left-column

style

left-column

style

right-column

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。

保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com

FITC Anti-Cytokeratin 18 抗体 [C-04]

FITC Anti-Cytokeratin 18 antibody [C-04]

Flow Cytometry (Intracellular) - FITC Anti-Cytokeratin 18 antibody [C-04] (AB52459)

Immunocytochemistry - FITC Anti-Cytokeratin 18 antibody [C-04] (AB52459)

Flow Cytometry (Intracellular) - FITC Anti-Cytokeratin 18 antibody [C-04] (AB52459)

Flow Cytometry (Intracellular) - FITC Anti-Cytokeratin 18 antibody [C-04] (AB52459)

Flow Cytometry (Intracellular) - FITC Anti-Cytokeratin 18 antibody [C-04] (AB52459)

関連する標識済み抗体及び組成の異なる製品 (1)

Key facts

宿主種

クローン性

クローン番号

アイソタイプ

標識

励起波長/蛍光波長

キャリアフリー

交差種

アプリケーション

免疫原

代替製品

Primary Antibodies

Primary Antibodies

Primary Antibodies

Primary Antibodies

Primary Antibodies

Primary Antibodies

組合せ製品

Assay Kits

Primary Antibodies

Primary Antibodies

Primary Antibodies

Primary Antibodies

Reactivity data

出荷温度及び保存条件

製品の状態

精製方法

精製に関する特記事項

バッファー組成

出荷温度

短期保存温度

長期保存温度

補足情報

Biological function summary

Pathways

製品プロトコール

ターゲットの情報

文献 (16)

Abcam product promise